Osaic Holdings
MBRX icon

Osaic Holdings’s Moleculin Biotech MBRX Stock Holding History

Osaic Holdings’s Portfolio MBRX Stock Details MBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2 Hold
1
– – ﹤0.01% 7780
2025
Q4 		$3 Sell
1
-1
-50% -$9 ﹤0.01% 7797
2025
Q3 		$20 Hold
2
– – ﹤0.01% 7826
2025
Q2 		$12 Hold
2
– – ﹤0.01% 7676
2025
Q1 		$41 Hold
2
– – ﹤0.01% 7302
2024
Q4 		$83 Buy
2
+1
+100% +$61 ﹤0.01% 7261
2024
Q3 		$65 Hold
1
– – ﹤0.01% 7281
2024
Q2 		$81 Sell
1
-2
-67% -$231 ﹤0.01% 7265
2024
Q1 		$384 Hold
3
– – ﹤0.01% 6871
2023
Q4 		$831 Hold
3
– – ﹤0.01% 6811
2023
Q3 		$414 Hold
3
– – ﹤0.01% 7029
2023
Q2 		$560 Hold
3
– – ﹤0.01% 7024
2023
Q1 		$930 Hold
3
– – ﹤0.01% 6979
2022
Q4 		$1.35K Sell
3
-8
-73% -$3.38K ﹤0.01% 6799
2022
Q3 		$4K Hold
11
– – ﹤0.01% 6493
2022
Q2 		$6K Hold
11
– – ﹤0.01% 6392
2022
Q1 		$7K Buy
11
+9
+450% +$5.16K ﹤0.01% 6331
2021
Q4 		$1K Hold
2
– – ﹤0.01% 7210
2021
Q3 		$2K Hold
2
– – ﹤0.01% 6868
2021
Q2 		$3K Hold
2
– – ﹤0.01% 6601
2021
Q1 		$3K Hold
2
– – ﹤0.01% 6379
2020
Q4 		$4K Sell
2
-3
-60% -$5.32K ﹤0.01% 5859
2020
Q3 		$9K Buy
5
+4
+400% +$8.5K ﹤0.01% 5329
2020
Q2 		$3K Buy
+1
New +$2.37K ﹤0.01% 5675

Other funds holding MBRX

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM

Osaic Holdings's MBRX Position: Q1 2026 in Review

Osaic Holdings held its Moleculin Biotech (MBRX) position steady in Q1 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #7780.

Osaic Holdings first reported a position in MBRX in Q2 2020 and has held it in 24 quarters since. The position peaked at $9K in Q3 2020. 20 funds tracked by Wall St. Rank hold MBRX as of Q1 2026.

  • Osaic Holdings held 1 share of Moleculin Biotech worth $2 as of Q1 2026.
  • Osaic Holdings left its Moleculin Biotech share count unchanged in Q1 2026.
  • Moleculin Biotech made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7780 holding.
  • Osaic Holdings first reported a position in Moleculin Biotech in Q2 2020 and has held it in 24 quarters since.
  • Osaic Holdings's Moleculin Biotech position peaked at $9K in Q3 2020.
  • 20 funds tracked by Wall St. Rank held Moleculin Biotech as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.